BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31299112)

  • 1. Deregulation of Ikaros expression in B-1 cells: New insights in the malignant transformation to chronic lymphocytic leukemia.
    Oliveira VC; Lacerda MP; Moraes BBM; Gomes CP; Maricato JT; Souza OF; Schenkman S; Pesquero JB; Moretti NS; Rodrigues CA; Popi AF
    J Leukoc Biol; 2019 Sep; 106(3):581-594. PubMed ID: 31299112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.
    Maffei R; Fiorcari S; Benatti S; Atene CG; Martinelli S; Zucchini P; Potenza L; Luppi M; Marasca R
    Leukemia; 2021 May; 35(5):1330-1343. PubMed ID: 33623139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications.
    Billot K; Soeur J; Chereau F; Arrouss I; Merle-Béral H; Huang ME; Mazier D; Baud V; Rebollo A
    Blood; 2011 Feb; 117(6):1917-27. PubMed ID: 21139082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concerted action of Helios and Ikaros controls the expression of the inositol 5-phosphatase SHIP.
    Alinikula J; Kohonen P; Nera KP; Lassila O
    Eur J Immunol; 2010 Sep; 40(9):2599-607. PubMed ID: 20602434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells.
    Schwickert TA; Tagoh H; Schindler K; Fischer M; Jaritz M; Busslinger M
    Nat Immunol; 2019 Nov; 20(11):1517-1529. PubMed ID: 31591571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
    Lorenzo-Herrero S; Sordo-Bahamonde C; Bretones G; Payer ÁR; González-Rodríguez AP; González-García E; Pérez-Escuredo J; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S; López-Soto A
    Front Immunol; 2019; 10():2455. PubMed ID: 31681329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ikaros limits follicular B cell activation by regulating B cell receptor signaling pathways.
    Heizmann B; Sellars M; Macias-Garcia A; Chan S; Kastner P
    Biochem Biophys Res Commun; 2016 Feb; 470(3):714-720. PubMed ID: 26775846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2.
    von Wenserski L; Schultheiß C; Bolz S; Schliffke S; Simnica D; Willscher E; Gerull H; Wolters-Eisfeld G; Riecken K; Fehse B; Altfeld M; Nollau P; Binder M
    Leukemia; 2021 Apr; 35(4):1073-1086. PubMed ID: 32826957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
    Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
    Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation.
    Lazarian G; Yin S; Ten Hacken E; Sewastianik T; Uduman M; Font-Tello A; Gohil SH; Li S; Kim E; Joyal H; Billington L; Witten E; Zheng M; Huang T; Severgnini M; Lefebvre V; Rassenti LZ; Gutierrez C; Georgopoulos K; Ott CJ; Wang L; Kipps TJ; Burger JA; Livak KJ; Neuberg DS; Baran-Marszak F; Cymbalista F; Carrasco RD; Wu CJ
    Cancer Cell; 2021 Mar; 39(3):380-393.e8. PubMed ID: 33689703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.
    McKenna MK; Noothi SK; Alhakeem SS; Oben KZ; Greene JT; Mani R; Perry KL; Collard JP; Rivas JR; Hildebrandt GC; Fleischman RA; Durbin EB; Byrd JC; Wang C; Muthusamy N; Rangnekar VM; Bondada S
    Blood; 2018 Jun; 131(26):2943-2954. PubMed ID: 29695515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
    Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
    J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.
    Cragg MS; Chan HT; Fox MD; Tutt A; Smith A; Oscier DG; Hamblin TJ; Glennie MJ
    Blood; 2002 Nov; 100(9):3068-76. PubMed ID: 12384401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.
    Mongini PK; Gupta R; Boyle E; Nieto J; Lee H; Stein J; Bandovic J; Stankovic T; Barrientos J; Kolitz JE; Allen SL; Rai K; Chu CC; Chiorazzi N
    J Immunol; 2015 Aug; 195(3):901-23. PubMed ID: 26136429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients.
    Perez-Chacon G; Vargas JA; Jorda J; Alvarez N; Martin-Donaire T; Rosado S; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
    Leuk Lymphoma; 2007 Jan; 48(1):147-57. PubMed ID: 17325858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
    Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional circuits in B cell transformation.
    Hu Y; Yoshida T; Georgopoulos K
    Curr Opin Hematol; 2017 Jul; 24(4):345-352. PubMed ID: 28463873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells.
    Vallat LD; Park Y; Li C; Gribben JG
    Blood; 2007 May; 109(9):3989-97. PubMed ID: 17234734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
    Seda V; Mraz M
    Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.